Out-patient chlorthalidone treatment identified similar sub-groups of patients with low- or normal-renin hypertension as the inpatient sodium-restriction test, whereas frusemide did not.
Observational (n=49)
Do out-patient renin-stimulating methods (frusemide or chlorthalidone) accurately identify low-renin hypertension compared to in-patient sodium restriction in hypertensive patients?
An out-patient 5-day chlorthalidone test is a reliable alternative to in-patient sodium restriction for identifying low-renin hypertension, whereas frusemide stimulation is not.
Three-renin-stimulating methods for detection of low-renin hypertension have been compared. First, renin activity was measured in hospital patients after 5 days of sodium restriction and 3 h ambulation. Secondly, renin activity was measured after frusemide stimualtion 0.42 mmol (140 mg) in 18 h and 3 h ambulation. Thirdly, renin activity was measured after 5 days of chlorthalidone treatment 0.3 mmol (100 mg/dayured after 5 days of chlorthalidone treatment 0.3 mmol (100 mg)/day and 3 h ambulation. The last two tests were done with the subjects as out-patients without any dietary regimen. 2. In eleven normotensive control subjects and twenty hypertensive patients the results after frusemide were not comparable with those after sodium restriction since the frusemide test did not identify the same renin-suppressed hypertensive subjects as the sodium-restriction procedure. 3. After 5 days of chlorthalidone treatment in the renin values in eleven control subjects as well as in thirty-eight hypertensive patients were significantly higher than after sodium restriction. The values obtained after each procedure were closely correlated. 4. Thus the out-patinet chlorthalidone procedure identified similar sub-groups of patients as having low- or normal-renin hypertension as did the inpatient sodium-restriction test.
Drayer et al. (Sat,) conducted a observational in Hypertension (n=49). Out-patient chlorthalidone and frusemide stimulation vs. Inpatient sodium restriction for 5 days was evaluated on Identification of low- or normal-renin hypertension. Out-patient chlorthalidone treatment identified similar sub-groups of patients with low- or normal-renin hypertension as the inpatient sodium-restriction test, whereas frusemide did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: